Phosphoprotein phosphatase 2A dephosphorylates eIF-4E and does not alter binding to the mRNA cap  by Bu, Xin & Hagedorn, Curt H.
Volume 301, number I. 15-18 FEBS 10906 
Q 1992 Federation of European l3iochcmicul Socictics 00145793/92/J5.00 
April 1992 
Phosphoprotein phosphatase 2A dephosphorylates eIF-4E and does not 
alter binding to the mRNA cap 
Xin Bu and Curt H. Hagedorn 
Rcccived I3 January 1992 
The phosphorylation end dcphosphorylation l’thc 25 kDa mRNA c.~p binding prowin cukaryolic initialion fxlor-4E (clF-4E) is rcgulawd uring 
ditTcrcnt physiologic and puthophysiologic smtc’s thut include crll growth and the lute phusc oTtidenovirus infection. WC huvc found that okadaic 
ucid is much m:re cl’fcctivc in increasing 111~’ phosphorylatcd lhction cd clF-?E thun phorbol 12~myristutc 13.acctatc in Hcp G? cells. Phospho- 
protein phosphntnsr 2A dcphosphorylatcd cIF-4E isoltitcd I’rom boil1 phurbol 12-myristuw 13.ucctatc- or okaduic acid-trcatcd cells. whcrcas 
alkulinc end acid phosphutusc wjcrc rclutivcly inclli-ctivc. The ubility ol’puriticd vS]clF-4E isolutcd from okadaio acid-(rcatcd cells IO bind mKNA 
caps was compvrcd to phosphoprotcin phosph;ttasc ?A-trcatod [‘%]clF-4E and Ibund to bc no diB’crcnt. This suggests that nltcrnativc cxplanutions 
for the previously obscrvcd cni’cts of elF-4E phosphorylution on pro:cin synthesis must bc considered. In addition, our rusulls indicate that the 
in viva phosphorylation of clF3E is not catulyzcd solrly by protcin kinusc C. 
mRNA c;~p binding protein; clF-4E; Phosphoprotcin phospl~u~asc ?A: Okadaic ucid: Hcp G?; Trunslution 
1. INTRODUCTION 
The 25 kDa mRNA cap binding protein cukaryotic 
initiation factor-4E (eIF-4E) exists in botll an isolated 
state and as a multisubunit complex (eIF-4F) that ap 
pears to be required for efficient binding of most cukar- 
yotic mRNA to 48 S ribosoma! complexes [l-6]. Both 
elF-4E and cIF-4F appear to be present in less than a 
I:! molar ratio with cellular mRNA [7,8]. Increases in 
the phosphorylation state of elF-4E Ilavc been found to 
occur after the addition of pyrroline-5-curboxylate to 
reticulocyte lysates and following tllc treatment of cul- 
tured cells with phorbol !2-myristatc I3-acetate (TPA) 
of the regulatory peptides, epidermal growth factor 
(EGF), platelet-derived growth factor (PDGF), insulin 
and tumor necrosis factor a (TNF-a) [9--171. In addi- 
tion, dephosphorylation of elF-4E occurs during mito- 
sis, heat shock, and the late phase of adcnovirus infec- 
tion which are all associated with decreases in protein 
synthesis [7,18,!9]. Protein kinase C, casein kinase I and 
at least one other partially characterized protein kinase 
are capable of phosphorylating eIF-4E in vitro [20-231. 
Although tryptic phosphopeptide map stud& indicate 
that only protein kinasc C phosphorylates an in vivo 
site, the phosphorylation sites of clF-4E have been 
characterized under limited physiologic conditions 
[ 16,221. At the present ime it remains unclear if protein 
kinase C is the sole enzyme catalyzing el F-4E phospho- 
rylation following the activation of EGF. PDGF, in- 
sulin and TNF-cc signal transduction pathways [I I-141. 
The in vivo effects of okadaic acid on eIF-4E phos- 
phorylation support an involvement of either phospho- 
protein phosphates 1 and/or 2A [I X4]. However. the 
phosphatases responsible for the rapid turnover of 
[J2P]eIF-4E intact cells have not been identified and 
studied with regard lo eIF-4E [24]. In addition, there 
has been no direct evidence determining if dcphos- 
phorylation of native eIF-4E affects its interaction with 
mRNA caps. 
2. MATERIALS AND METHODS 
Ahhrc~*iutlorts: m’GTP, 7-mcihylguanosinc triphosphatc; elF, cukur- 
yotic initiation Btctor; EGF. cpidcrmal growth Actor: PDGF. pluiclct- 
dcrivcd growth Ihclor; TNF-a. tumor necrosis factor-a: DTT. dithio- 
threitol; PAGE, polyacrylamidc ycl clectrophorcsis; PMSF, phcn- 
ylmclhyl sulfonyl fluoride: TPA. phorbol 12.myristatc 13.acetutc: 
IEF, isoelectric focusing, 
7.Mahylguanosinc triphosphatc (m’GTP) Scphurosc and ampho- 
lytcs were f’rom Phurmucia LKB Biotechnology Inc, (Piscutuw;ly. NJ). 
r2P]orthophosphate (1,201 Ci/mmol) and [‘~S]mcthionc/cystcinc 
( I. 134 Ci/mmol were Born ICN Biomcdiculs Inc. (Irvine. CA). Oku- 
duic acid was from Mounti BioProducts Inc. (Honolulu. Hawaii). 
Protein phosphatasc 2A, bovine cardiac Walylic subunit. was kindly 
provided by Marc Mumby of the University or Texas. Southwestern 
Health Scicnccs Center (Dallas. TX) [?!I). All other rcagcnts wcrc from 
Sigmu Chemical Co. (SI. Louis, MO). 
Corrcq:orn/cnrr ;rr(:!rrs,~: X. 3~. C-Z!!04 Medical Ccn!cr North, Yen- 
derbih University School of Medicine. Nashville, TN 37232. USA. 
Fax: (I) ((515) 343.6229. l-iuman heputoblastomu cells (Hcp G2) wcrc obiaincd Born the 
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Fig. I, Dcphosphorylation of in vivo phosphorylated elF4E by the catalytic subunh of phosphoprotein phosphatase 2A. [“P]cl F-4E was isolated 
from Hcp CX cells trcatcd with 100 ngml ofTPA Tar 3 has described in Materials and Methods. (A) Time-dcpcndent dcphosphorylation ol’cl F-4E 
by phosphoprotcin phosphutase ?A. (B) Dcnsitomctric quantitation of [“?P]clF4E following incubation with diKerent quuntities of phosphoprolcin 
phosphu~asc ZA. The quantity orphosphatusc 2A catalytic subunit in incubations were I pg (0) and 2 yg (0). At the indicated titxcs samples wcrc 
rcmovcd. analyzed by SDS-PAGE and uutorttdiogrophy and [?]elF4E quantitated by dcnsitomctry, The insert in B shows ;1n uutorudiogrdm 
01’ samples umllyzed ut ditTcrcnt incubations times in the presence ol’ I jrg (A) and 1 pg (B) ol’ phosphoprotcin phosphiltuX 2A. (C) The rclutivc 
rutc ol’cIF;IE Jephosphorylution by acid phoyhutuse, ulkalinc phasphutasc and phusphatasc ?A. ~‘:P]cIF-~E isolated from TPA-treated Hcp G2 
cells was used ;IS ;I substr;ltc to ;~ssuy relutivc rates of phosphutusc activity, Incubntions were at 30°C in 50 mM TridHCl (pH 8.0) for slk;rlinc 
phosph;~~usc. 50 mM sodium citrate (pH 5.5) for ucid phosphirtasc und 20 IIIM HEPES (pH 7.5) Ibr phosphoprotcin phosphutusc ?A. Incubations 
wcrc I50 ,uI by volu~nc and contuincd 2 /~g OT alkulinc phosphutusc, 2 rug of acid phosphtitasc und 2 pg or phosphatasc 2A. Sumples were removed 
ut ~hc indicutcd time and ;m;llyzcd by SDS-PAGE. autoradiography and dcnsitomctry. The quantity ol’ [J2P]clF-4E given as percent of control (0 
min) l’or cxh incubation ia shown where (0) rcprcscnts iilkaline phosphitttise. (m) rcprcscnts acid phosphatase und (0) represents phosphat;~sc ?A. 
The insert shows an tlutoradiogrum of [“?P]clF-;IE removed from incubations at the indicutcd times. 
Amcrian Type Culture Collection (Rockville. MD). Cells were grown 
i<\ confluent monoluyers in Euglc’s minimum csscntial medium 
(MEM) with L-glutamine, non-csscntiul uminoncids. sodium pyruvutc 
und antibiotics supplemcntcd with 10% hcdt-inactivated fetal call 
strum (Hyclonc Laboratory Inc.) PS described clscwhcre [I I], Cells 
wcrc wilshcd with Dulbccco’s moditicd Eagle’s medium (minus phos- 
phntc or mcthioninc) and incubated in this medium at 37°C Ibr 2 h. 
Medium was rcmovcd following this prc-incubation and replaced with 
mcdium containing p2P]orthophosph:tte or [“S]mcthionine/cystcine 
(0.5 mCi/ml). Cells were then incubated iit 37°C without other addi- 
tions or with IO0 @ml oTTPA or IO0 IIM okadaic acid for the times 
indicutcd in IIX tigurc Icgcnds, 
2.3. Isolrrriort of c/F-4E 
Labclcd cells wcrc wushcd with ice-cold phosphate buffered sulinc 
and lysed on ice by gcnily rocking with I ml of lysis burfcr (20 mM 
HEPES, pH 7.5. 100 mlvl KCI. 50 mM P-glyccrolphosphau, 10% 
glycerol, 0.2 mM EDTA, 0.2 mM sodium vanadate, OS% ‘Won 
X-100. 7 mM /f-mcrcuptoc~hanol, I mM PMSF. lO~g/ml Icupcptin. 
IOflgInil aprotinin) Tar 30 min. clF-4E was isolated from lysutcs using 
16 
m’GTP Scphurosc us described in dct;lil elscwhcre [I I]. SDS-PAGE 
end cquilihrium isoclcctric l&using (IEF) ;Inalysis nT elF-4E Was 
pcrl’ormcd as described elscwhcre [23]. Phosphoamino acid analysis 
was pcformcd as described clsewhcre [23]. 
[“‘PIelF-4E isolutcd l*rom intact Hep G2 cells was incubuled with or 
without protein phosphatasc 2A at 30°C for the limes indicated in the 
Agure legends. Incubations were 150/d and contained 20 mM HEPES, 
pH 7.5, I mM dithiothreitol and 10% glycerol. Equal volume aliquots 
ol’ each incubation wcrc taken at the indicaied tinlea and udded to 
sample buffer. [JzD]elF-4E was sepurdted by 10% SDS-PAGE, aurora- 
diagrams prcparcd and [“?P]clF-4E quantitated by densitometry. 
3. RESULTS AND DISCUSSION 
The identification of a phosphoproteill phosphatasc 
that extensively dcphosphorylates eIF-4E would be use- 
ful in determining if the in vivo phosphorylatior. of 
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Fig, 1, Effect ol’ TPA and okaduic ticid on the rccovcry 01. phospho- 
rylud clF-4E t’rom intttct cells. Hcp GZ cells wcrc labclcd with 
~‘“S]mcthiotlitic/cystcinc itlId imtcd with TPA or ok;ld:tic iicid for 3 
h. clF-4E w’;ts isol;ncd ils dcscribcd in M;ttcrinls tind Methods md 
analyzed by equilibrium IEF. This figure show XII :tutorndiopr;m~ 01 
311 IEF pcl ol’[“S]cIF-4E isolated I’I’OIII control (IUC I). TPA (I:IIIC 2) 
and ok;td:tic acid (lux 3).trcutcd cells. The m;ljor phosphoryluted 
species is closest to the anode (+ j, Dcnsitomctry illdiCiItCd 1Il;ll 1llC 
three isoclcctric spccics ol’ clF-4E (vulucs givw I’rom uthodc to 
:IIIO~C) under each condition rcprcscntcd 83. IO utd 7% (control): 78. 
8 ilnd 14% (TPA): und IX. 8 and 74% (okxlnic xid) ol’thc total, The 
anode (-) ;ind catliodc ( f ) regions of the gel xc indicated in the ligurc. 
eIF-4E affects its function, Hcp G2 cells were metaboli- 
cally labeled with )‘P, treated with TPA to stimulate 
eIF-4E phosphorylation. and ctF4E isolated using 
m’GTP Scpharose as described. We found that purified 
phosphoprotcin phosphatase 2A dephosphorylated 
[“‘PIelF-4E isolated f rom intact cells in a time- and 
dose-dependent manner (Fig. I). In addition. relative to 
phosphoprotein phosphatasc 2A. both alkaline and acid 
phosphatasc wcrc ineffective in dcphosphorylating 
[“‘PJelF-4E isolated from intact cells (Fig. IC). 
To determine the optimal method of maximaliy phos- 
phorylating eIF-4E at in vivo sites we compared the 
ability of TPA and okadaic acid to increase the phos- 
phorylated fraction of cIF-4E. Hep G2 celis were in- 
cubated in the presence of [‘!S]methionine/cysteine for 
3 h with either TPA. okadaic acid or no additions and 
the phosphorylation state of eIF-4E isolated from these 
cells was quantitated by IEF analysis. Treatment ofcells 
with okadais acid proved to be effective in preparing 
eIF-4E that existed primarily (at least 74% in the phos- 
phorylated state (Fig. 2). The observation that TPA 
treatment of cells was relatively ineffective in preparing 
in viva pilosphorylated eIF-4E suggests that protein 
kinase C is not the so!e enzyme catalyzing physiologic 
eIF-4E phosphorylation (Fig. 2). 
WC used the okadaic acid treatment of cells and in 
vitro phosphoprotcin phosphatase 3A treatment to pre- 
pare phosphorylated and dephosphorylated cIF-4E and 
directly determine if in vivo phosphorylation of eIF-4E 
altered its ability to interact with the mRNA cap struc- 
ture. No difference in the &iiity of phosphorylated or 
dephosphorylated IF-4E to bind to m’GTP Sepharose 
was detected (Fig. 3A). IEF analysis of the eIF-4E 
bound to m’GTP Sepharose verified that the control 
(lane I) was primarily phosphorylatcd (denoted by B) 
and that the phosphatase 2A-treated elF-4E bound to 
m’GTP Sepharose was predominantly dephosphorylat- 
ed (denoted by A) (Fig. 3B). 
Based on our results we conclude that the in vivo 
phosphorylation of eIF-4E does not dramatically alter 
its ability to bind to the mRNA cap moiety in a purified 
system. This direct evidence argues against phospho- 
rylated eIF-4E binding to mRNA caps with higher af- 
finity (Fig. 4. model I) as an explanation for the obser- 
vation that in reticulocytc cell-free systems phos- 
phorylated forms of eIF-4E stimulate protein synthesis 
and are preferentially incorporated into 46 S prcinitia- 
tion complexes [26,27]. One possible explanation for 
this paradox is that phosphorylation of eIF-4E effects 
the assembly of the eIF-4E complex and/or the affinity 
by which the complex binds to the m’GTP cap of 
mRNAs (Fig. 4, model 2). The dephosphorylation of 
cIF-4E that occurs during the late phase of adenovirus 
infection quay provide a useful probe to address this 
question in intact cells [ 191. An alternative approach to 
testing this hypothesis will be to use functional elF-4E 
components overcxpressed in E. coii and purified pro- 
tein kinases that phosphorylate in vivo sites in recon- 
stituted systems. 
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Fig, 3. Ability 01 drphosphoryletcd and phosphorylated [r%]cIF.ilE to bind thr mRNA cup structure. Hep G2 cells wcrc incubutcd with 
[““S]methioninc/cystcinc und okadeic acid for 3 h. clF-4E wcs isolutid from cell lystltcs und equal qunntitics incubtltcd in cithcr the prcscncc OI 
absence ol’ phosphoprotein phosphatasc ?A us described in Fig. I. After a I I1 incubation 400~1 of bovine scrurn ulbumin (I m&ml) was uddcd 
and stmplcs dialyzed ugainst three exchanges (I I each) of 20 mM HEPES, pH 7.5. I IIIM DTT und 10% glycerol over I%?0 h to remove the m’GDP 
initially used to elute clF-4E. SumpIes wcic mixrd with 25 ~1 (puckcd volume) ol’m’GTP Scphurosc Ibr IO min und then w;~slml two times with 
buffer. eIF4E that rcmaincd bound to m’GTP Srphsrosc wus analyzed by SDSPAGE ~111 iluorography. (A) Control (lane I ) und dcphospho- 
r_ylnted clFs4E (lane 2) bound to m’GTP Scphurosc. The arrow indicutcs ciF-4E. (B) IEF anulysis oTcIF-4E that bound to m’GTP Scph;trosc 
following control slnd phosphtitasu trcatmont (sl~ow in A). Lane I contuincd untrcurcd~ and lunc 1 contained phosphutusc ?A-trcutcd clF-4E. 
Model I : increased Affinity 
m7GTP .,LAAA 
Model 2 : Protein - Profeln Interactions 
===-AAA 
Fig. 4. Two hypothetical mod& for the elTccts oTclF4E phosphoryl- 
zttion that have been reported previously [38,19,26,27]. The results WC 
report here argue tiguinst model I whcrc phosphorylation or clFs4E 
simply mddifics its interaction with the mRNA cap. An ;tltcrnativc 
hypothesis is that clF4E phosphorylation modifies protein-protein 
intcrections within the clF-4F complex and that this cithcr promotes 
assembly of an active cIF-4E complex. incrcascs the catalytic activity 
of the complex or incrcascs the affinity with which the entire complex 
intcructs with the mRNA cup structure. 
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